What Abbis does

Abbis Oy is a Finland-based digital health platform, founded in 2025 and headquartered in Espoo, that offers affordable preventive blood testing for dogs and cats. The company sells four test packages through its own e-commerce site at abbis.app: two basic panels (Koira and Kissa, each with 7 biomarkers at €119) and two comprehensive Plus panels (Koira Plus with 24 biomarkers at €189, including the proprietary CFD® cell-free DNA marker, and Kissa Plus with 19 biomarkers at €169). Customers order online, book sample collection appointments at a network of partner veterinary clinics (Sacrum in Vantaa, SoVet and Joy in Espoo), and receive digital results in their Abbis profile within 1-3 business days, with AI-assisted verbal explanations of the lab values.

The platform is built on standard SaaS infrastructure: Stripe/Kustom for payments, Supabase for user data, PostHog for analytics, and Resend for transactional email. The differentiated technology layer is the CFD® biomarker, provided through a strategic partnership with DeepScan Diagnostics Oy, which measures circulating cell-free DNA and is currently exclusive to the Koira Plus package; pet health and demographic data shared with DeepScan feeds their algorithm development. The service is explicitly positioned as complementary to, not a replacement for, veterinary care.

Commercially, Abbis operates a one-time unit-pricing DTC model with no subscription tier, generates revenue only in Finland, and has no disclosed institutional funding. The four founders (Simon, Antti, Rebecka, Henrik) operate alongside a contracted veterinarian (Tove Tuovio) with 25 years of internal-medicine experience, and the company is affiliated with Helsinki Incubators (Cohort 6, Spring 2025). Distribution relies on Instagram (@abbis.fi), TikTok (@myabbis), and organic content marketing, with clinic-partner expansion publicly signaled as the next growth lever.

Name

Abbis

Legal name

Abbis Oy

Website

https://abbis.app

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Abbis Oy is a Finland-based digital platform offering affordable preventive blood tests for dogs and cats via its own e-commerce site, with sample collection at partner veterinary clinics in the Helsinki metropolitan area and digital results delivered in 1-3 business days.

Ownership category

akta.pro rank

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Blood Test Kit Sales: Direct e-commerce sales of blood test packages for dogs and cats. Customers order through the Abbis website and visit partner clinics for sample collection. Results are delivered digitally within 1-3 business days.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Abbis is a Finnish digital platform offering affordable preventive blood tests for dogs and cats. Customers order test packages online, book sample collection appointments at partner veterinary clinics, and receive digitally delivered results within 1-3 business days. The service includes four test tiers (Koira, Koira Plus, Kissa, Kissa Plus) ranging from €119 to €189, with comprehensive packages incorporating proprietary CFD® biomarker analytics.

Product overview

Abbis is a digital platform offering affordable blood tests for dogs and cats through a network of partner veterinary clinics. The core offering consists of four test packages: two basic tests (Koira and Kissa, each containing 7 values at 119€) and two comprehensive Plus packages (Koira Plus with 24 values at 189€ and Kissa Plus with 19 values at 169€). The service operates through a digital marketplace where customers order tests online, book sample collection appointments at partner clinics, and receive results digitally in their Abbis profile within 1-3 business days. Results are presented with clear reference values and easy-to-understand explanations. Koira Plus includes proprietary CFD® biomarker analytics provided by DeepScan Diagnostics Oy.

Differentiator

Problem solved

Functional benefit

Products and services

• Koira (Dog) Blood Test Basic blood test package containing 7 values that helps establish a clear baseline of a dog's health and detect changes over time. Measures key values related to liver and kidney function as well as blood protein balance. Priced at €119.00.
• Koira Plus (Dog Plus) Blood Test Comprehensive blood test containing 24 values, the most extensive test for dogs. Includes CRP (inflammation marker), CFD® biomarker (cell-free DNA measuring cell breakdown), and biomarkers for liver/kidney function, immune system, and blood count. Especially recommended for senior dogs and at-risk breeds. Priced at €189.00.
• Kissa (Cat) Blood Test Basic blood test package containing 7 values. Includes key biomarkers for liver, kidneys, and blood proteins. Helps identify abnormalities that may indicate common hidden diseases such as kidney dysfunction. Priced at €119.00.
• Kissa Plus (Cat Plus) Blood Test Comprehensive blood test package containing 19 values, the most extensive test for cats. Includes key values for kidney and thyroid function, inflammation, immune system, and blood count. Especially recommended for senior cats to detect changes early and influence quality of life and lifespan. Priced at €169.00.

Quantifiable outcome

• Results delivered within 1-3 business days after sample collection
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature1 record

Partnerships

Eight partnerships are on record, tiered strategic, core and supporting.

• Helsinki IncubatorsstrategicOthers · 1 January 2025Abbis participated in Helsinki Incubators pre-incubator program, Cohort 6 Spring 2025, which is part of the University of Helsinki's startup support network.
• DeepScan Diagnostics OycoreTechnology or IntegrationDeepScan Diagnostics provides CFD® biomarker analytics for Abbis's Koira Plus test package. The CFD® biomarker measures circulating cell-free DNA related to cell degradation. Abbis shares pet-related data (breed, age, weight, gender, reproduction status, and test results) with DeepScan for analysis, validation, quality assurance, research, analytics, algorithm development, and product development purposes.
• Eläinsairaala Sacrum (Sacrum Animal Hospital)coreChannel Partner/ Reseller/ DistributorPartner veterinary clinic in Vantaa (Porttisuontie 13, 01200 Vantaa) open weekdays 9-19. Performs blood sample collection for Abbis tests.
• Eläinlääkärikeskus SoVetcoreChannel Partner/ Reseller/ DistributorPartner veterinary clinic in Espoo (Nuijalantie 13, 02630 Espoo) open weekdays 12:30-15:30. Performs blood sample collection for Abbis tests.
• Eläinklinikka JoycoreChannel Partner/ Reseller/ DistributorPartner veterinary clinic in Espoo (Nuijalantie 13, 02630 Espoo) open Tue-Thu 13-15:30. Performs blood sample collection for Abbis tests.
• IDEXXsupportingTechnology or IntegrationLaboratory services provider for veterinary diagnostics. Referenced in privacy policy as one of the laboratory service providers used by Abbis for test analysis.
• Stripe Inc.supportingTechnology or IntegrationPayment processor used by Abbis for handling customer payments through their e-commerce platform. Customers accept Stripe's terms when making payments.
• SupabasesupportingTechnology or IntegrationRelational database used by Abbis for user authentication and customer data storage.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Basepaws: Direct-to-consumer cat and dog genetic and oral-health testing brand, now part of Zoetis. Comparable D2C pet health testing approach; key overlap is the cat-owner preventive testing segment that Abbis also serves with Kissa and Kissa Plus.
• Wisdom Panel: Mars Petcare-owned D2C pet DNA testing brand. Comparable D2C pet health testing model with digital results; differs in genetic versus blood-biomarker focus but targets the same pet-owner preventive-care wallet.
• Embark Veterinary: Direct-to-consumer dog DNA and health testing brand with proprietary genetic markers and digital reporting. Comparable D2C pet health testing brand targeting dog owners with multi-value digital reports and a premium price-point.
• PetDx: US-based veterinary diagnostics company commercializing cell-free DNA (cfDNA) liquid biopsy testing for canine cancer. Closely comparable because both companies commercialize cfDNA biomarkers in companion animals, even though PetDx focuses on oncology while Abbis uses CFD® for preventive monitoring.
• MySimplePetLab: Direct-to-consumer pet health testing platform offering at-home and partner-collected sample tests with online results. Highly comparable D2C model, multi-animal panels, and digital result delivery mirror Abbis's marketplace structure.

Broad incumbents

• Ceva Santé Animale: Global animal health company spanning pharmaceuticals, vaccines, and digital pet-health services. Comparable broader animal-health incumbent expanding into digital preventive-care products relevant to Abbis's category.
• Antech Diagnostics: Mars Petcare-owned veterinary diagnostics network with reference labs and in-clinic instruments across North America. Comparable incumbent with established vet-clinic relationships; relevant as a potential strategic acquirer or competitor entering the European preventive-care segment.
• IDEXX Laboratories: Global leader in veterinary diagnostics and lab services, and Abbis's own lab partner. Operates a far broader reference-lab and in-clinic analyzer portfolio; comparable because IDEXX sets the pricing, turnaround, and clinical-trust benchmarks Abbis must compete against.

Emerging players

• Vetster: Telehealth marketplace connecting pet owners with licensed veterinarians. Comparable as a digital platform intermediating between pet owners and veterinary professionals, though Vetster focuses on consultations while Abbis focuses on diagnostics.
• MiDog: Direct-to-consumer pet microbiome and health testing service for dogs and cats. Comparable emerging D2C pet health testing brand with a multi-marker digital results approach, though microbiome-focused rather than blood-biomarker-focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/abbis.fi
• TikToktiktok.com/@myabbis
• LinkedInlinkedin.com/company/abbisapp

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbis